Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Esperion Therapeutics, Inc. ESPR
$1.52
+$0.03 (2.01%)
На 18:00, 12 мая 2023
+952.63%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
130489601.00000000
-
week52high
8.87
-
week52low
1.12
-
Revenue
75475000
-
P/E TTM
0
-
Beta
0.12145300
-
EPS
-3.63000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 12:00
Описание компании
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Credit Suisse | Underperform | Neutral | 03 авг 2022 г. |
| Morgan Stanley | Underweight | Underweight | 15 июл 2022 г. |
| Goldman Sachs | Sell | Sell | 24 мая 2022 г. |
| JP Morgan | Neutral | Underweight | 05 мая 2022 г. |
| HC Wainwright & Co. | Buy | 10 мар 2022 г. | |
| Morgan Stanley | Underweight | Underweight | 02 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Underweight | 03 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Foody Joanne M. | D | 106944 | 1191 | 18 янв 2023 г. |
| Looker Benjamin | D | 64453 | 6347 | 18 янв 2023 г. |
| Halladay Benjamin | A | 66000 | 66000 | 09 дек 2022 г. |
| Halladay Benjamin | A | 63771 | 44000 | 09 дек 2022 г. |
| Foody Joanne M. | D | 108135 | 942 | 18 окт 2022 г. |
| Warren Eric | D | 53662 | 107 | 18 окт 2022 г. |
| Koenig Sheldon L. | D | 198257 | 3394 | 19 сент 2022 г. |
| Warren Eric | D | 53769 | 255 | 19 сент 2022 г. |
| Warren Eric | A | 54024 | 1000 | 31 авг 2022 г. |
| Warren Eric | D | 53024 | 199 | 17 авг 2022 г. |
Новостная лента
Esperion (ESPR) Q1 Earnings Miss Estimates, Sales Beat, Stock Up
Zacks Investment Research
10 мая 2023 г. в 11:26
Esperion (ESPR) reports mixed first-quarter 2023 results, wherein earnings miss and revenues beat estimates. The stock of the company surges 5% on Tuesday.
Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 09:56
Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.93 per share a year ago.
7 Very Undervalued Penny Stocks to Buy in April 2023
InvestorPlace
06 апр 2023 г. в 17:39
Investors are attracted to penny stocks for their potential to provide exponential gains. It is very common to find such companies trading for fractions of their target price.
Top 5 Health Care Stocks That Preparing To Pump This Quarter - Enovis (NYSE:ENOV), Esperion Therapeutics (NASDAQ:ESPR)
Benzinga
29 мар 2023 г. в 07:28
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Penny Stocks To Buy Now? 3 Short Squeeze Stock To Watch
PennyStocks
27 мар 2023 г. в 14:14
Short squeeze penny stocks for your watch list. The post Penny Stocks To Buy Now?